{"name":"Serpin Pharma, LLC","slug":"serpin-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SP16","genericName":"SP16","slug":"sp16","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"SP16","genericName":"SP16","slug":"sp16","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQeWhWTmJhS0JVeXVENl9ENV9SYUVETDNtRjdUcXBJdXNOVkJGSW9FMldoQUs2eWE2dUpYQmkxQUZ5ZUo0RTNxajV4S2o3NEVUZkcxakJEY1UtUHAxSmhFd1kwc2tTYmlBOFBHNk9FU19mdHhBUTZiekxGN2d3djg0ZUowelBsaS1BUDlYZWIyczRkZnpsb3JWS3lVajcxbGdGdTNjVV9Qd2ZuV2JpQmhkNXBqc0xmb3NmNXNtNjdrYU1ObGo1SUZEQmNzVFJ5SWdCZnk0bkxQV0lXdDhjSzNGRmdHNVA5cURMQVdkNGxBczNfcTRXcmJLNmdsWWxiUzNJYi1VUjM5bnlTR0dmT1BZd0dZdWoxOHdGRGFj?oc=5","date":"2026-02-23","type":"pipeline","source":"GlobeNewswire","summary":"Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment - GlobeNewswire","headline":"Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQR3VRcVRCYmZ2bVBnZ292em52cUljakhDTWJBWFlkVE9abDBSbUN6RkhlS2VwQUxkNmZFT0RsbDRkc1lVTE1IOHNJQnkzT3V4eHl4WmVrRGdCX09ISjFkcmJpQ3dPMkQ0MEVrd2hyVVdoaUp2Y21zc2FuNURGbVh3bzRNMHhBZklZQ3JHQmFNNTFnbm1ueFM0akRxWFUxS0QxYmd6YllJY2lsYmhnV0VPcWZnSQ?oc=5","date":"2025-02-26","type":"pipeline","source":"wwd.com","summary":"The Estée Lauder Cos. Looks to Pharmaceutical Industry for New Ingredients - wwd.com","headline":"The Estée Lauder Cos. Looks to Pharmaceutical Industry for New Ingredients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNV25BVERVWnlocFRjUDNITlRKQmtnUEw3eHJKUi16ZnJtUURHTTN5ZGN3S1M3dDMybzU1OEoxNDhZM2pVeFhydTJXTVVFUDN6MWUyZzRkZXFQNURobTNVbGU0Ukt0dlNNVGV2WkMtcnNmdGl5aEh4ajFaZ3RJaElJWjBycWdjSnFaV2x3UVBwdHE2UDNENmlwUExVQ0hicWxYak1lVTJmMA?oc=5","date":"2024-11-12","type":"regulatory","source":"Fierce Biotech","summary":"Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval - Fierce Biotech","headline":"Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPMi0tTkVVUXQ2VDNlMWw2TFlsN1laazJ6dHM3Q0ZNOTNoT2o3TW1SVnhQMks4UndpUk9MLXRwOGdScUNiYnNHRGJ5Wlc5NWpXNXdSRjZscndYRkhyNjJla1BEUzViUHhVazJ5Vi1kSVhFTno0X3BNT3lnLVVCbjNSZnhMemVNSzdmakRn?oc=5","date":"2023-11-23","type":"pipeline","source":"BioWorld News","summary":"Serpin Pharma describes new LRP-1 agonists - BioWorld News","headline":"Serpin Pharma describes new LRP-1 agonists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5ZM3pCdFVaZTdTdTRKajFveEtPUnRKWFU1S29KNm9ZMGZTTzJvd3FlMG9DeGMyb1VpbHNzWXg4bFBTaGxwVUNPTTJpUDFRSmlkQm45VGFFcmRXRWg4dWJOZU5RRXNleVU?oc=5","date":"2022-02-27","type":"pipeline","source":"MedPage Today","summary":"Dupilumab Continues to Show Promise in Eosinophilic Esophagitis - MedPage Today","headline":"Dupilumab Continues to Show Promise in Eosinophilic Esophagitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbENJaEN2UDR3Z0xGc3dnWUt5SU9Pd1NsdERGSWpLUm45Y1pnWXhKZmVuSVpvcHExWGtJUDQzdDQ0SWp1dUlUdjRNLVZrXzQtdlVfbXFwM21ZNXlvTThWYWJnMUJwWUlLQnJ2cXJFVGxobXRaRlFZbkhNdHBJVk5zQ3ZscHJuYmd2VzdpVkN1RkhDejVMcnpIbnllT2F0M0c3STJkMnNNUms0MUxLOXpLM3NYM0RMZC1wOWZUa1NtWW8?oc=5","date":"2021-03-08","type":"pipeline","source":"WTOP","summary":"Serpin Pharma “graduates” Prince William Science Accelerator - WTOP","headline":"Serpin Pharma “graduates” Prince William Science Accelerator","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}